MSL
PACB icon

Mackay Shields LLC’s Pacific Biosciences PACB Stock Holding History

Mackay Shields LLC’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-43,700
Closed -$1.46M – 1140
2021
Q1 		$1.46M Sell
43,700
-32,100
-42% -$1.12M 0.01% 889
2020
Q4 		$1.97M Buy
75,800
+51,000
+206% +$867K 0.01% 860
2020
Q3 		$244K Buy
+24,800
New +$143K ﹤0.01% 1301

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackay Shields LLC's PACB Position: Q2 2021 in Review

Mackay Shields LLC sold out of Pacific Biosciences (PACB) in Q2 2021, closing a stake of 43,700 shares — an estimated $1.46M sold.

Mackay Shields LLC first reported a position in PACB in Q3 2020 and held it in 3 quarters. The position peaked at $1.97M in Q4 2020. 262 funds tracked by Wall St. Rank hold PACB as of Q2 2021.

  • Mackay Shields LLC reported no remaining Pacific Biosciences position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 43,700 Pacific Biosciences shares in Q2 2021, an estimated $1.46M.
  • Mackay Shields LLC first reported a position in Pacific Biosciences in Q3 2020 and held it in 3 quarters.
  • Mackay Shields LLC's Pacific Biosciences position peaked at $1.97M in Q4 2020.
  • 262 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.